Rita Siksniute
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rita Siksniute has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Danguole Vaznaisiene
Department of Infectious Diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania
1 shared publication - Justinas Stucinskas
Department of Orthopaedics and Traumatology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania
1 shared publication - Kristina Marcinkeviciene
Laboratory of Microbiology, Centre of Laboratory Medicine, Vilnius University Hospital Santaros Klinikos, LT-08661 Vilnius, Lithuania
1 shared publication - Kristina Valatkevičienė
Department of Radiology, Medical Academy, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania
1 shared publication - Rokas Jurkonis
Department of Orthopaedics and Traumatology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania
1 shared publication - Silvija Kiveryte
Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania
1 shared publication
Latest Publications
- Open Access
- 8 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (4) , 509
Actinomycetoma Caused by Gordonia rubripertincta: Case Report
Background: Mycetoma is a chronic infectious disease caused by bacteria or fungi which typically affects the skin, deep tissues, and bones. This case involves bone mycetoma in an immunocompetent patient, marking the first known instance of actinomycetoma caused by Gordonia rubripertincta. Case Report: A 25-year-old male presented with severe pain and deformity in his left foot, symptoms that began five years prior after stepping on a wire. Initial surgery provided temporary relief, but symptoms worsened over time. Doxycycline treatment was ineffective. Skin biopsies were performed. The patient was diagnosed with actinomycetoma, with Gordonia rubripertincta identified in culture. Although initial improvement was observed with amoxicillin–clavulanate treatment, the condition later worsened, requiring long-term penicillin therapy and eventual surgical excision. Despite treatment, symptoms persisted, leading to a bone biopsy that showed no microorganism growth. A six-week course of ampicillin–sulbactam and ciprofloxacin, along with offloading, decreased pain and stabilized radiological findings. Conclusion: Gordonia infections mean there is no universally established treatment protocol. This case underscores the diagnostic and therapeutic challenges associated with mycetoma, particularly in non-tropical regions.
- 8 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (4) , 509
Open AccessActinomycetoma Caused by Gordonia rubripertincta: Case Report
Background: Mycetoma is a chronic infectious disease caused by bacteria or fungi which typically affects the skin, deep tissues, and bones. This case involves bone mycetoma in an immunocompetent patient, marking the first known instance of actinomycetoma caused by Gordonia rubripertincta. Case Report: A 25-year-old male presented with severe pain and deformity in his left foot, symptoms that began five years prior after stepping on a wire. Initial surgery provided temporary relief, but symptoms worsened over time. Doxycycline treatment was ineffective. Skin biopsies were performed. The patient was diagnosed with actinomycetoma, with Gordonia rubripertincta identified in culture. Although initial improvement was observed with amoxicillin–clavulanate treatment, the condition later worsened, requiring long-term penicillin therapy and eventual surgical excision. Despite treatment, symptoms persisted, leading to a bone biopsy that showed no microorganism growth. A six-week course of ampicillin–sulbactam and ciprofloxacin, along with offloading, decreased pain and stabilized radiological findings. Conclusion: Gordonia infections mean there is no universally established treatment protocol. This case underscores the diagnostic and therapeutic challenges associated with mycetoma, particularly in non-tropical regions.